American Diabetes Association (ADA)
Pathway to Stop Diabetes
Visionary Award
On This Page
**$1.625M Limited ADA “Visionary" Award funding opportunity for established senior investigators (faculty with PI eligibility) with exceptional productivity in fields other than diabetes research who would like to apply their expertise to innovative diabetes-related research topics. The program intends to attract a broad range of expertise to the field of diabetes from various fields of science and technology, including medicine, biology, chemistry, engineering, mathematics and physics.
The 2018 internal deadline has passed. This webpage is for your reference only.
This is one of three related limited ADA Pathway to Stop Diabetes Awards.
The other two programs are:
- Initiator Award (postdoc-to-faculty transition award) more >>
- Accelerator Award (assist. prof. with PI eligibility with demonstrated independent productivity in diabetes research) more >>
# of applicants: 1*
* Stanford is permitted ONE total nomination. It can be either an "Initiator" or an "Accelerator", or a "Visionary" applicant.
Timeline
Internal deadline: Tuesday, April 3, 2018, 5 p.m. (see the internal submission guidelines below)
For applicant selected:
Institutional representative (RPM/RMG) deadline: June 25, 2018
Sponsor deadline: July 2, 2018
Start date for funding: Jan. 1, 2019
Amount of funding:
Phase 1 provides up to three years of support at a maximum of $325,000 per year (including 30% indirect costs),
Phase 2* provides up to two years of support at a maximum of $325,000 per year (including 30% indirect costs).
*Phase 2 is contingent upon demonstration of significant contributions to the field of diabetes research in Phase 1. Combined support for Phase 1 and Phase 2 can total up to $1,625,000.
Guidelines
Download the application guidelines from this ADA webpage:
http://professional.diabetes.org/meetings/pathway-stop-diabetes%C2%AE
However, please see the eligibility and purpose sections and the internal submission guidelines on this webpage.
- Applicants must be established senior investigators (faculty with PI eligibility-with UTL, MCL, NTL-Research appts.) with exceptional productivity in fields other than diabetes research who would like to apply their expertise to innovative diabetes-related research topics. Applicants must hold faculty positions and have demonstrated independent productivity.
- Candidate’s appointment at the Sponsoring Institution must be full-time. Rare exceptions to full-time positions may be granted on a case-by-case basis and must be pre-approved by Pathway administration staff prior to application submission.
- Not eligible: Instructors, Clinical Instructors and Academic staff-research (i.e., basic scientists, senior research associates) are not eligible because Stanford does not consider those positions to be independent or faculty positions.
- Applicants cannot have previously received national grant support (NIH, NIDDK, ADA, JDRF, etc.), as either a PI or Co-PI, in diabetes or diabetes-related research.
- Applicants must hold a MD, PhD, DMD, DO, PharmD, DVM or an equivalent health- or science-related degree.
- Individuals must have permission to work within the U.S., either as U.S. citizens or permanent residents, or with appropriate work visas/permits. Institutional certification of permission to work within the U.S. will be required prior to activation of the award.
- One person must be specified as the PI; co-PIs are not permitted.
- Visionary applicants must agree to devote at least 75% of total time and effort towards research during the period of Association funding. In other words, 75% of the PI’s time overall must be dedicated to research. This percentage includes time dedicated to the Association-funded grant in addition to grants supported by other funding agencies.
Purpose
The Pathway Visionary Award is designed to support established, experienced investigators (faculty with PI eligibility) with strong records of outstanding productivity in fields outside of diabetes who are interested in applying their considerable skills and expertise to diabetes research. These awards are highly competitive and intended to support particularly innovative and transformational ideas that have the potential to have an exceptional impact in diabetes. In order to be competitive for this award, investigators should have:
- 1) a significant publication history including high-impact senior author publications in their current field,
- 2) a demonstrated ability to obtain sustained, independent funding/support for their work, and
- 3) strong evidence of outstanding creativity, insight, and a demonstrated ability to collaborate.
Research Topics:
The Pathway to Stop Diabetes Research Program will consider applications directed toward all topics rele-vant to prevention, treatment and cure of all types of diabetes (type 1, type 2, and gestational diabetes), diabetes-related disease states (obesity, pre-diabetes, and other insulin resistant states) and the complica-tions of the disease. The program intends to attract a broad range of expertise to the field of diabetes from various fields of science and technology, including medicine, biology, chemistry, engineering, mathematics and physics.
Types of research: can be basic, clinical, or translational. For the purpose of this award, clinical research is defined as research directly involving humans, and includes educational, psychosocial, behavioral, epidemiologic, and health services research as well as clinical studies of normal physiology and mechanisms of disease. Translational research is defined as research that accelerates the transition of scientific discoveries into clinical applications, by efficiently advancing knowledge of efficacy to the next level of clinical application.
Review Criteria
Scientific excellence is the primary benchmark to be evaluated for all Pathway applications, with an emphasis on the investigator’s potential to significantly impact the field of diabetes research. The proposed research strategy serves as a reflection of the individual’s capacity for innovation, creativity and collaboration. The review will include the following components:
Principal Investigator:
- Proven ability to establish and sustain an independent and successful research program in their primary discipline
- Proven ability for creativity, collaboration and innovation
- Institutional commitment to the investigator and the project
Research Strategy:
- Clear evidence of a new direction of research significant to the field of diabetes
- Innovation and creativity
- Clarity of thought and approach
- Potential impact for understanding/treatment of diabetes
Internal submission guidelines
By Tuesday, April 3, 2018, 5 p.m., please submit one PDF file containing the following in the order listed below to:
Jeanne Heschele
Research Management Group (RMG)
jheschele@stanford.edu
650-245-2351
File name: Last name_ADA_Visionary.pdf
Faculty: You do not have to prepare a budget, or submit a PDRF form or proposals through your institutional representative (RPM or OSR)
1) Title Page
American Diabetes Association (ADA) Pathway to Stop Diabetes “Visionary Award"
Indicate Diabetes category relevant to the research: both Type 1 and Type 2 Diabetes; Type 1 Diabetes, Type 2 diabetes, Gestational Diabetes, obesity, pre-diabetes/insulin resistance
Research type: basic, clinical or translational
Project Title:
PI name, appointment, Department, address, phone, email
2) Nomination letter printed on your department or division's letterhead signed by your Division Chief or your Department Chair addressed to Dr. Peter Sarnow and the Awards Committee members.
Provide rationale for your nomination of candidate, including why candidate is uniquely suited for the award.
Certify that the candidate has the appropriate full-time position at the sponsoring institution as required by the award.
Outline the candidate’s responsibilities and ensure that at least 75% of the nominee’s total time and effort will be allocated to research during the term of this award.
3) "Research Strategy" Proposal- up to 4 page maximum
Formatting guidelines: Single-spaced, 1/2 inch margins, Font size 11 or larger, Ariel or Helvetica font. Figures can be included in the 4 page limit. References can be on a separate page and are not included in the four page limit
The research strategy should provide a high level description of your scientific question(s) and the strategy(ies) and approach(es) that you will employ to address this question. It should be written with a level of detail appropriate for reviewers who are knowledgeable of the field, but who may not be directly involved in the proposed area of research. The Research strategy section is flexible in format, does not require a detailed project plan or description of methods, or preliminary data. Figures are allowed, but must be included in the 4 page limit.
The research strategy should address the following components:
a) Scientific question(s)/specific problem(s) to be addressed
b) Specific approach(es) that will be employed
c) Significance and potential impact of the work
d) The potential risks and challenges, and how they will be overcome
4) NIH Biosketch
5) Other support (include current and pending support, sponsor, term, amount of funding)
Selection process
Your proposals will be reviewed by the School of Medicine Awards Committee. That committee will select the applicant to represent Stanford. (Note: there can only be one applicant- either an Accelerator, an Initiator, or a "Visionary" applicant)
